The Food and Drug Administration (FDA) gave Eli Lilly’s antibody drug emergency-use authorization on Monday, Nov. 9. Early data has strongly suggested that the pharmaceutical company’s antibody drug is effective at keeping people with mild to moderate cases of the Wuhan coronavirus (COVID-19) from needing to get admitted to a hospital. The FDA extended the emergency approval to the experimental therapy known … Continue reading FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment
Dr. Eddy Bettermann MD 